These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30301603)

  • 1. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Rosie Xing H
    EBioMedicine; 2018 Nov; 37():47-55. PubMed ID: 30301603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A8 transported by SEC23A inhibits metastatic colonization via autocrine activation of autophagy.
    Sun Z; Zeng B; Liu D; Zhao Q; Wang J; Rosie Xing H
    Cell Death Dis; 2020 Aug; 11(8):650. PubMed ID: 32811814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway.
    Zeng B; Sun Z; Zhao Q; Liu D; Chen H; Li X; Xing HR; Wang J
    Int J Biol Sci; 2021; 17(12):3000-3012. PubMed ID: 34421345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression" [EBioMedicine 37 (2018) 47-55].
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Xing HR
    EBioMedicine; 2021 Aug; 70():103508. PubMed ID: 34364168
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA expression characterizes oligometastasis(es).
    Lussier YA; Xing HR; Salama JK; Khodarev NN; Huang Y; Zhang Q; Khan SA; Yang X; Hasselle MD; Darga TE; Malik R; Fan H; Perakis S; Filippo M; Corbin K; Lee Y; Posner MC; Chmura SJ; Hellman S; Weichselbaum RR
    PLoS One; 2011; 6(12):e28650. PubMed ID: 22174856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.
    Zeng B; Chen Y; Chen H; Zhao Q; Sun Z; Liu D; Li X; Zhang Y; Wang J; Xing HR
    Mol Oncol; 2023 Dec; 17(12):2743-2766. PubMed ID: 37356089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
    Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
    World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
    Korpal M; Ell BJ; Buffa FM; Ibrahim T; Blanco MA; Celià-Terrassa T; Mercatali L; Khan Z; Goodarzi H; Hua Y; Wei Y; Hu G; Garcia BA; Ragoussis J; Amadori D; Harris AL; Kang Y
    Nat Med; 2011 Aug; 17(9):1101-8. PubMed ID: 21822286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
    Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
    Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma.
    Barbai T; Fejős Z; Puskas LG; Tímár J; Rásó E
    Oncotarget; 2015 Oct; 6(30):29111-28. PubMed ID: 26320180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
    Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
    BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
    Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
    PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
    Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W
    Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.